A detailed history of Us Bancorp \De\ transactions in Atri Cure, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 997 shares of ATRC stock, worth $29,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares
997
Previous 1,466 31.99%
Holding current value
$29,341
Previous $33,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$20.34 - $29.5 $9,539 - $13,835
-469 Reduced 31.99%
997 $27,000
Q2 2024

Aug 06, 2024

BUY
$19.86 - $29.09 $7,288 - $10,676
367 Added 33.39%
1,466 $33,000
Q1 2024

May 07, 2024

SELL
$28.21 - $37.78 $16,418 - $21,987
-582 Reduced 34.62%
1,099 $33,000
Q4 2023

Feb 09, 2024

BUY
$32.99 - $43.25 $32,792 - $42,990
994 Added 144.69%
1,681 $59,000
Q3 2023

Nov 03, 2023

SELL
$41.12 - $57.73 $2,056 - $2,886
-50 Reduced 6.78%
687 $30,000
Q1 2023

May 09, 2023

SELL
$35.87 - $47.22 $5,595 - $7,366
-156 Reduced 17.47%
737 $30,000
Q4 2022

Feb 13, 2023

SELL
$33.48 - $47.45 $84,704 - $120,048
-2,530 Reduced 73.91%
893 $39,000
Q3 2022

Oct 27, 2022

SELL
$38.25 - $52.62 $306 - $420
-8 Reduced 0.23%
3,423 $134,000
Q2 2022

Aug 01, 2022

SELL
$35.1 - $66.01 $6,739 - $12,673
-192 Reduced 5.3%
3,431 $140,000
Q1 2022

May 11, 2022

BUY
$57.43 - $71.39 $1,263 - $1,570
22 Added 0.61%
3,623 $238,000
Q4 2021

Feb 11, 2022

SELL
$63.4 - $87.14 $15,152 - $20,826
-239 Reduced 6.22%
3,601 $250,000
Q3 2021

Nov 10, 2021

SELL
$69.28 - $84.46 $8,867 - $10,810
-128 Reduced 3.23%
3,840 $267,000
Q2 2021

Aug 05, 2021

SELL
$64.13 - $80.18 $19,495 - $24,374
-304 Reduced 7.12%
3,968 $315,000
Q1 2021

Apr 28, 2021

SELL
$53.79 - $66.98 $24,205 - $30,141
-450 Reduced 9.53%
4,272 $279,000
Q4 2020

Feb 04, 2021

BUY
$34.56 - $57.55 $50,630 - $84,310
1,465 Added 44.98%
4,722 $263,000
Q3 2020

Nov 10, 2020

BUY
$38.36 - $46.91 $11,009 - $13,463
287 Added 9.66%
3,257 $130,000
Q2 2020

Aug 07, 2020

BUY
$31.78 - $51.19 $24,470 - $39,416
770 Added 35.0%
2,970 $134,000
Q1 2020

May 13, 2020

SELL
$24.49 - $43.84 $19,738 - $35,335
-806 Reduced 26.81%
2,200 $74,000
Q3 2019

Nov 08, 2019

SELL
$23.81 - $32.52 $10,571 - $14,438
-444 Reduced 12.87%
3,006 $75,000
Q2 2019

Aug 13, 2019

SELL
$26.85 - $30.74 $11,921 - $13,648
-444 Reduced 11.4%
3,450 $103,000
Q1 2019

May 08, 2019

BUY
$26.38 - $33.34 $38,066 - $48,109
1,443 Added 58.87%
3,894 $104,000
Q4 2018

Feb 13, 2019

BUY
$26.66 - $34.85 $3,599 - $4,704
135 Added 5.83%
2,451 $75,000
Q3 2018

Nov 01, 2018

BUY
$27.62 - $35.58 $45,186 - $58,208
1,636 Added 240.59%
2,316 $81,000
Q2 2018

Aug 08, 2018

SELL
$19.65 - $30.28 $49,262 - $75,911
-2,507 Reduced 78.66%
680 $18,000
Q1 2018

May 08, 2018

SELL
$15.05 - $21.03 $16,675 - $23,301
-1,108 Reduced 25.8%
3,187 $65,000
Q4 2017

Feb 02, 2018

SELL
$17.69 - $23.44 $5,696 - $7,547
-322 Reduced 6.97%
4,295 $79,000
Q3 2017

Nov 13, 2017

BUY
$20.0 - $24.23 $92,340 - $111,869
4,617
4,617 $103,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.37B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.